Avenciguat
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Boehringer Ingelheim
Overview
Avenciguat is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Avenciguat clinical trials
Explore related
Medical disclaimer. This page summarizes research about Avenciguat for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.